Collaborate

Doctor-led BioSignal systems · Breath as the first interface

Breath carries biology.We are building systems to measure it.

VSNOVA is building a biological-measurement platform around breath: physical sampling and sensing, source-aware computation and a clinic-connected respiratory programme. Each intended use advances through its own reference method and validation.

Explore the platformSee the system map
NowVAYU development + respiratory programmeHorizonIndication-specific biological intelligence
Physics around biologyMeasurement around uncertainty

VSNOVA in one view

Four views of one biological measurement system.

Move from the shared architecture to physical systems, clinical operations and the people responsible for building them.

  1. 01Measurement platform

    How a breath signal becomes a bounded estimate

    Explore the platform
  2. 02Product systems

    A staged family of breath capture and sensing devices

    View product systems
  3. 03Clinical programme

    Respiratory continuity with gut-health context

    Enter the programme
  4. 04Company

    Doctor-led science, built from India for wider validation

    Meet VSNOVA

Product systems

A platform should survive more than one enclosure.

VAYU is the first physical build. The longer product architecture considers controlled collection and context sensing at different scales, with readiness stated explicitly.

Concept visualisation of the VSNOVA product family, with the VAYU clinic instrument, a portable breath sampler and a respiratory context node
01
Active physical buildVAYU clinic instrument

The central controlled-capture and sensing system now in development.

Product-family concept visualisation. Readiness differs by system, and only VAYU is the active physical product in development.
View the product systemEnter the VAYU build

Application horizons

Shared measurement core. Separate claims.

A platform is not permission to use one model everywhere. Each disease area needs its own endpoint, cohort, comparator and external validation.

  1. 01
    Current operating focus

    Chronic respiratory continuity

    A clinic-connected programme beginning with COPD and other chronic lung disorders.

  2. 02
    Measurement research

    Gut-lung phenotyping

    Testing whether selected gut microbial functions and gut-lung phenotypes can be estimated reproducibly from exhaled signatures.

  3. 03
    Future validation

    Lung oncology

    Earlier-signal, response and recurrence research, each tested against established diagnostics before any clinical claim.

  4. 04
    Separate research pathway

    Gut-brain and cognition

    Independent cohorts and biomarkers for questions linking microbial function, metabolism and cognition.

Lung oncology · long-term validation

Can breath reveal an earlier lung cancer signal?

Detection is only one part of solving cancer. Our long-term ambition is to test whether controlled, repeated breath signatures can add an earlier signal, then support research into response and recurrence alongside imaging, pathology and molecular diagnostics.

VSNOVA does not currently screen for, diagnose, monitor or treat cancer. Every oncology use requires a separate endpoint, prospective evidence, independent validation and regulatory review.

Review the emerging evidenceSee why source correction matters
ONCOLOGY / FUTURE VALIDATIONCONCEPTUAL · NOT PATIENT DATA
Conceptual signal illustration for future lung-oncology research. This is not patient data.
01
Future study questionCould a controlled breath pattern add signal before symptoms?

A future screening-support question, tested only against established reference diagnostics in an appropriate cohort.

Controlled breathLocked endpointIndependent comparison

Long-horizon research · Sentinel biology

Could unusual respiratory biology be recognised earlier?

Infectious processes can alter host metabolism, airway inflammation and microbial activity. VSNOVA's long-term research asks whether, in defined respiratory cohorts, controlled breath measurements could flag atypical patterns early enough to prioritise confirmatory testing.

Virus-associated breath VOC studyWHO sentinel-surveillance guidance
  1. 01
    Phenotype

    Host response + microbial metabolism

    Investigate VOC patterns associated with biological response, not a universal pathogen fingerprint.

  2. 02
    Future capture pathway

    Exhaled particles + target-specific assays

    Explore purpose-built aerosol or condensate collection for target-specific laboratory assays.

  3. 03
    Preparedness research

    Aggregate anomaly signals

    Study privacy-preserving approaches to aggregate departures from a defined baseline under clinical and public-health governance.

This is a research horizon, not a current infection diagnostic, outbreak detector or biothreat identification system. Pathogen, strain and source require validated molecular or microbiological assays plus public-health investigation.

Build the evidence with us

One breath is simple. Making it comparable is not.

We are opening conversations with clinics, VOC laboratories, microbiome researchers, sensor engineers and public-health research groups.

Start a conversation